Cargando…

Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials

BACKGROUND: To date, only dexamethasone and tocilizumab have been shown to reduce mortality in patients with COVID-19. Baricitinib is a Janus kinase 1/2 inhibitor with known anti-inflammatory and anti-viral properties. We performed a meta-analysis of RCTs assessing the role of baricitinib in hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvaraj, Vijairam, Finn, Arkadiy, Lal, Amos, Khan, Mohammad Saud, Dapaah-Afriyie, Kwame, Carino, Gerardo P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163705/ https://www.ncbi.nlm.nih.gov/pubmed/35677732 http://dx.doi.org/10.1016/j.eclinm.2022.101489

Ejemplares similares

BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: SELVARAJ, VIJAIRAM, et al.
Publicado: (2022)

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
por: Selvaraj, Vijairam, et al.
Publicado: (2021)

Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Management of the Patient with Chronic Critical Illness – Part 1: This is part one of a two part series. Part two will be published in September
por: Finn, Arkadiy, et al.
Publicado: (2022)

Management of the Patient with Chronic Critical Illness – Part 2
por: Finn, Arkadiy, et al.
Publicado: (2022)

Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022)

Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

A Tale of Two Ps: Panniculitis Secondary to Acute Pancreatitis
por: Selvaraj, Vijairam, et al.
Publicado: (2021)

Complete heart block associated with Remdesivir in COVID-19: a case report
por: Selvaraj, Vijairam, et al.
Publicado: (2021)

COVID-19-induced granulomatosis with polyangiitis
por: Selvaraj, Vijairam, et al.
Publicado: (2021)

In-hospital clinical complications of COVID-19: a brief overview
por: John, Kevin John, et al.
Publicado: (2021)

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
por: Wolfe, Cameron R, et al.
Publicado: (2022)

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
por: Marconi, Vincent C, et al.
Publicado: (2021)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Heart failure in COVID-19 patients: Critical care experience
por: John, Kevin John, et al.
Publicado: (2022)

Baricitinib for the Management of SARS-CoV-2-Infected Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Manoharan, Sivananthan, et al.
Publicado: (2022)

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
por: Ely, E Wesley, et al.
Publicado: (2022)

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Publicado: (2022)

Hospitalisation for bed rest for women with a triplet pregnancy: an abandoned randomised controlled trial and meta-analysis
por: Dodd, Jodie M, et al.
Publicado: (2005)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Baricitinib for the treatment of rheumatoid arthritis
por: Urits, Ivan, et al.
Publicado: (2020)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
por: Philip, Anil Mathew, et al.
Publicado: (2021)

Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials
por: Qiu, Chengfeng, et al.
Publicado: (2019)

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
por: Taylor, Peter C., et al.
Publicado: (2023)

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial
por: Kralj-Hans, Ines, et al.
Publicado: (2023)

Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis
por: Harigai, Masayoshi, et al.
Publicado: (2020)

15. Eosinophilic pneumonitis secondary to baricitinib
por: Yein, Khin, et al.
Publicado: (2019)

Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019)

Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022)

Efficacy and Safety of Isotonic and Hypotonic Intravenous Maintenance Fluids in Hospitalised Children: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Hasim, Norfarahin, et al.
Publicado: (2021)

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Amstutz, Alain, et al.
Publicado: (2023)

The efficacy of Protected Mealtimes in hospitalised patients: a stepped wedge cluster randomised controlled trial
por: Porter, Judi, et al.
Publicado: (2017)

Hypotonic and isotonic intravenous maintenance fluids in hospitalised paediatric patients: a randomised controlled trial
por: Torres, Silvio Fabio, et al.
Publicado: (2019)

Navigator programme for hospitalised adults experiencing homelessness: protocol for a pragmatic randomised controlled trial
por: Liu, Michael, et al.
Publicado: (2022)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_80p19d8ih1ttk7j4iqi2p11a16